PP
GSK icon

PDT Partners’s GSK GSK Stock Holding History

PDT Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-86,449
Closed -$4.16M – 621
2015
Q3 		$4.16M Sell
86,449
-339,001
-80% -$17.6M 0.09% 263
2015
Q2 		$22.1M Buy
425,450
+163,855
+63% +$9.23M 0.58% 24
2015
Q1 		$15.1M Buy
261,595
+216,965
+486% +$12.4M 0.37% 46
2014
Q4 		$2.38M Sell
44,630
-179,563
-80% -$10M 0.23% 96
2014
Q3 		$12.9M Buy
224,193
+196,701
+715% +$12.1M 0.33% 60
2014
Q2 		$1.84M Sell
27,492
-288,498
-91% -$19.5M 0.05% 462
2014
Q1 		$21.1M Buy
315,990
+183,699
+139% +$12.4M 0.51% 34
2013
Q4 		$8.83M Sell
132,291
-31,507
-19% -$2.04M 1.06% 10
2013
Q3 		$10.3M Buy
+163,798
New +$10.5M 0.28% 61

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PDT Partners's GSK Position: Q4 2015 in Review

PDT Partners sold out of GSK (GSK) in Q4 2015, closing a stake of 86,449 shares — an estimated $4.16M sold.

PDT Partners first reported a position in GSK in Q3 2013 and held it in 9 quarters. The position peaked at $22.1M in Q2 2015. 718 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

  • PDT Partners reported no remaining GSK position as of Q4 2015 after selling out during the quarter.
  • PDT Partners sold 86,449 GSK shares in Q4 2015, an estimated $4.16M.
  • PDT Partners first reported a position in GSK in Q3 2013 and held it in 9 quarters.
  • PDT Partners's GSK position peaked at $22.1M in Q2 2015.
  • 718 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on PDT Partners's 13F filing for Q4 2015, filed 16 Feb 2016.